Stockbabie NewsFatherMarketNewsMarket Intelligence
MARKETS
Wire · Markets
Markets

Revelation Biosciences Announces 1-For-7 Reverse Stock Split, Effective Oct. 20

Oct 16, 2026 · 09:03 AM ET· updated 2h ago

Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, announced today

Share
Why It Matters

Revelation Biosciences is combining every 7 shares into 1 share. This is a common move when a stock price gets too low to stay listed on exchanges.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
REVB0.50
-0.27 (-34.98%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.